Born in Naples, Italy October 11 – 1962, Dr. Antonio Giordano is a Professor of Molecular Biology at Temple University in Philadelphia and a ‘Chiara fama’ Professor in the Department of Pathology & Oncology at the University of Siena, in Siena, Italy. Dr. Antonio Giordano is also the Director of the Sbarro Institute for Cancer Research and Molecular Medicine and the Center for Biotechnology at Temple’s College of Science & Technology.
He graduated with highest honors in Medicine from Naples in 1986, then received his specialization in Pathological Anatomy from the University of Trieste, later moving to the United States with a PhD as a student of Nobel Laureate Watson at Cold Spring Harbor Laboratory.
In 1992 he moved to Philadelphia as an assistant professor at Temple University
then to Thomas Jefferson University as full professor of Pathology before returning to Temple University where he is currently director of the Sbarro Institute for Cancer Research and Molecular Medicine and co-director of the Center for Biotechnology in the College of Science and Technology.
In 1993, Antonio Giordano, M.D., Ph.D., founded the Sbarro Health Research Organization Institute
with a generous donation from Mario Sbarro the Founder of the Sbarro restaurant chain, following Dr. Giordano’s discovery of the tumor suppressor gene pRb2, and cell cycle genes CDK9, CDK10. SHRO is a nonprofit dedicated to cancer research and training the next generation of scientists. Under his guidance, SHRO has grown into a global network of laboratories and partnerships, emphasizing innovation, mentorship, and equitable access to scientific opportunities.
Prof. Antonio Giordano has authored more than 400 publications in scientific journals, including international ones, and holds 15 international patents for the discovery of new genes and new methods for cancer diagnosis and therapy.
Since 1992, his research has been funded by the most prestigious American agencies: the National Institute of Health, the U.S. Department of Defense, and the Commonwealth of the State of Pennsylvania.
Prof. Antonio Giordano has authored more than 400 publications in scientific journals, including international ones, and holds 15 international patents for the discovery of new genes and new methods for cancer diagnosis and therapy.
Dr. Antonio Giordano has published over 600 papers on gene therapy, cell cycle, genetics of cancer, and epidemiology. Professor Giordano’s contributions have been celebrated globally. He is a recipient of the Order of the Star of Italy, one of the nation’s highest civilian honors, and a Fellow of the American Association for the Advancement of Science (AAAS).
His impact on cancer research
SHRO’s research does not stop at discovering therapies. We work to understand the biological and environmental mechanisms that lead to cancer.
Our efforts contribute to the identification of biomarkers, genetic risk factors, and early signs that can guide preventive strategies and public health campaigns.
1000
High-impact scientific publications.
400
Students in the Italy – USA exchange program.
70000
Citations of our studies on Google Scholar.